Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 31
2017
|
Bryan C Hanson EVP, President, MITG |
BUY
Grant, award, or other acquisition
|
Direct |
14,490
+8.71%
|
$1,202,670
$83.97 P/Share
|
|
Jul 31
2017
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
11,910
+16.57%
|
-
|
|
Jul 31
2017
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
53,591
+8.45%
|
-
|
|
Jul 31
2017
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,322
+8.31%
|
-
|
|
Jul 28
2017
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,872
-6.75%
|
$325,248
$84.29 P/Share
|
|
Jul 28
2017
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,094
-9.59%
|
$427,896
$84.29 P/Share
|
|
Jul 28
2017
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
28,522
-5.13%
|
$2,395,848
$84.29 P/Share
|
|
Jul 28
2017
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-0.64%
|
$27,720
$84.29 P/Share
|
|
Jul 28
2017
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,532
-7.77%
|
$296,688
$84.29 P/Share
|
|
Jul 28
2017
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,621
-4.27%
|
$388,164
$84.29 P/Share
|
|
Jul 28
2017
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
3,914
-6.54%
|
$328,776
$84.29 P/Share
|
|
Jul 28
2017
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
7,270
-4.93%
|
$610,680
$84.29 P/Share
|
|
Jul 17
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
12,000
-8.06%
|
$1,056,000
$88.57 P/Share
|
|
Jul 10
2017
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,010
+2.13%
|
$52,520
$52.84 P/Share
|
|
Jun 21
2017
|
Richard H Anderson Director |
BUY
Open market or private purchase
|
Direct |
5,600
+7.22%
|
$492,800
$88.9 P/Share
|
|
Jun 20
2017
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,047
-10.87%
|
$620,136
$88.82 P/Share
|
|
Jun 14
2017
|
Robert C Pozen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
628
-0.9%
|
$54,636
$87.65 P/Share
|
|
May 26
2017
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
647
-1.41%
|
$54,995
$85.09 P/Share
|
|
May 02
2017
|
Shirley A Jackson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-1.77%
|
$54,600
$84.75 P/Share
|
|
May 02
2017
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-11.96%
|
$54,600
$84.75 P/Share
|
|
May 02
2017
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-1.18%
|
$54,600
$84.75 P/Share
|
|
May 02
2017
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-2.25%
|
$54,600
$84.75 P/Share
|
|
May 02
2017
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-0.97%
|
$54,600
$84.75 P/Share
|
|
May 02
2017
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-2.32%
|
$54,600
$84.75 P/Share
|
|
May 02
2017
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-7.88%
|
$54,600
$84.75 P/Share
|
|
May 02
2017
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-1.88%
|
$54,600
$84.75 P/Share
|
|
May 01
2017
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+13.24%
|
-
|
|
May 01
2017
|
Shirley A Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+5.37%
|
-
|
|
May 01
2017
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+5.7%
|
-
|
|
May 01
2017
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+20.22%
|
-
|
|
May 01
2017
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+4.35%
|
-
|
|
May 01
2017
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+6.94%
|
-
|
|
May 01
2017
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+27.78%
|
-
|
|
May 01
2017
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+3.66%
|
-
|
|
May 01
2017
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+6.76%
|
-
|
|
May 01
2017
|
Robert C Pozen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+2.91%
|
-
|
|
May 01
2017
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+3.03%
|
-
|
|
Mar 20
2017
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct |
50,757
-49.76%
|
$4,111,317
$81.58 P/Share
|
|
Mar 20
2017
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Exercise of conversion of derivative security
|
Direct |
50,757
+13.23%
|
$2,436,336
$48.61 P/Share
|
|
Mar 15
2017
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
95,000
-14.71%
|
$7,790,000
$82.82 P/Share
|
|
Mar 15
2017
|
Omar Ishrak Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+10.41%
|
$2,850,000
$38.81 P/Share
|
|
Mar 02
2017
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
52,316
-47.03%
|
$4,289,912
$82.33 P/Share
|
|
Mar 02
2017
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
52,316
+14.2%
|
$3,243,592
$62.76 P/Share
|
|
Mar 02
2017
|
Randall J Hogan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,109
+31.76%
|
$407,943
$27.38 P/Share
|
|
Mar 01
2017
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,974
-21.19%
|
$571,868
$82.07 P/Share
|
|
Mar 01
2017
|
Craig Arnold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,109
+31.46%
|
$407,943
$27.38 P/Share
|
|
Feb 17
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,751
-1.17%
|
$136,578
$78.88 P/Share
|
|
Jan 05
2017
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,387
+3.75%
|
$182,898
$54.14 P/Share
|
|
Dec 30
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Bona fide gift
|
Direct |
10,000
-5.24%
|
-
|
|
Dec 13
2016
|
Robert C Pozen Director |
BUY
Open market or private purchase
|
Direct |
13,660
+16.89%
|
$997,180
$73.21 P/Share
|